You have 9 free searches left this month | for more free features.

14C-labeled gilteritinib

Showing 1 - 25 of 2,320

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Subjects, Pharmacokinetics of 14C-labeled of LXI-15028 Trial in Suzhou ([14C]LXI-15028)

Completed
  • Healthy Subjects
  • Pharmacokinetics of 14C-labeled of LXI-15028
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 22, 2023

Healthy Male Subjects Trial in Tokyo ([14C] TS-142)

Completed
  • Healthy Male Subjects
  • [14C] TS-142
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022

Healthy Male Volunteers Trial in Madison ([14C]-BMS-986196)

Not yet recruiting
  • Healthy Male Volunteers
  • Madison, Wisconsin
  • +1 more
Aug 1, 2023

Healthy Participants Trial in Groningen ([14C]-etrumadenant)

Completed
  • Healthy Participants
  • Groningen, NZ, Netherlands
    PRA Health Sciences (PRA) - Early Development Services (EDS)
Dec 6, 2022

Healthy Volunteers Trial in Madison (14C-labeled ASP0367)

Completed
  • Healthy Volunteers
  • 14C-labeled ASP0367
  • Madison, Wisconsin
    Labcorp CRU
May 24, 2022

Healthy Trial in Madison (Radio-labeled rodatristat ethyl 600 mg)

Completed
  • Healthy
  • Radio-labeled rodatristat ethyl 600 mg
  • Madison, Wisconsin
    Covance Clinical Research Unit
Jul 12, 2022

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
  • Cincinnati, Ohio
  • +18 more
Jan 20, 2023

Healthy Volunteers, Type 2 Diabetes Trial in Groningen (NNC0113-6861, NNC0113-6860, NNC0113-6891)

Completed
  • Healthy Volunteers
  • Type 2 Diabetes
  • Groningen, Netherlands
    Novo Nordisk Investigational Site
Apr 28, 2022

Advanced Solid Tumors, Pharmacokinetics of 14C-labeled Gilteritinib Trial in Cleveland (gilteritinib, 14C-labeled gilteritinib)

Completed
  • Advanced Solid Tumors
  • Pharmacokinetics of 14C-labeled Gilteritinib
  • Cleveland, Ohio
    Site US10001
Mar 13, 2019

Malaria Trial in Allschwil (14C-labeled Pyronaridine)

Completed
  • Malaria
  • 14C-labeled Pyronaridine
  • Allschwil, Basel, Switzerland
    Covance Clinical Research Unit AG
Nov 18, 2021

Solid Tumor Trial in Pittsburgh (14C-labeled poziotinib)

Terminated
  • Solid Tumor
  • 14C-labeled poziotinib
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jun 14, 2021

Tuberculosis, Tuberculosis, Pulmonary, Bacterial Infections Respiratory Trial in Groningen (500mg BTZ-043 containing 3.7 MBq of

Completed
  • Tuberculosis
  • +4 more
  • 500mg BTZ-043 containing 3.7 MBq of [14C]BTZ-043
  • Groningen, Netherlands
    PRA Health Sciences (PRA) - Early Development Services (EDS)
Oct 19, 2021

Pulmonary Arterial Hypertension Trial in Groningen (400 mg BIA 5-1058)

Completed
  • Pulmonary Arterial Hypertension
  • 400 mg BIA 5-1058
  • Groningen, Netherlands
    PRA Health Sciences (PRA) - Early Development Services (EDS)
Jul 28, 2021

Healthy Volunteers Trial in Nottingham ([12C] RO7049389, [13C] RO7049389, [14C] RO7049389)

Completed
  • Healthy Volunteers
  • [12C] RO7049389
  • +2 more
  • Nottingham, United Kingdom
    Quotient Sciences
Jul 21, 2021

COPD (COPD) Trial in Lincoln (TD-4208)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lincoln, Nebraska
    Celerion
Feb 22, 2022

ADHD, Fibromyalgia Trial in Lincoln (TD-9855)

Completed
  • ADHD
  • Fibromyalgia
  • Lincoln, Nebraska
    (unnamed)
Jan 15, 2021

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Healthy Trial in Zuidlaren (IPI-145)

Completed
  • Healthy
  • Zuidlaren, Netherlands
    Pharmaceuticals Research Association (PRA)
Mar 15, 2021

Healthy Trial in San Antonio (14C PER977)

Completed
  • Healthy
  • 14C PER977
  • San Antonio, Texas
    Worldwide Clinical Trials Early Phase Services
May 19, 2020

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Los Angeles, California
  • +110 more
Jan 26, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

Suspended
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Adelaide, Australia
  • +193 more
Jan 5, 2023

Healthy Volunteers Trial in Groningen ([14C]-CRN00808, CRN00808)

Completed
  • Healthy Volunteers
  • Groningen, Netherlands
    PRA Health Sciences
Jan 27, 2020

Hypertension Trial in Madison (baxdrostat)

Completed
  • Hypertension
  • Madison, Wisconsin
    Labcorp Clinical Research Unit
Jul 18, 2023

Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle-Cell Lymphoma Trial in Bebington, Liverpool (Tazemetostat

Completed
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • Tazemetostat and [14C] Tazemetostat
  • Bebington, Wirral, United Kingdom
  • +1 more
Jan 8, 2020

Mass Balance Study in Healthy Subjects Trial in Suzhou ([14C]JAB-21822)

Not yet recruiting
  • Mass Balance Study in Healthy Subjects
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 25, 2023